Table 1.
The clinical characteristics and statistics of GC cases included in this study (N = 74).
| Characteristics | No. (%) | PM | Non-PM | P valuea |
|---|---|---|---|---|
| Age | 0.112 | |||
| <60 | 28 (37.8) | 13 | 15 | |
| >=60 | 46 (62.2) | 13 | 33 | |
| Sex | 0.885 | |||
| Male | 52 (70.3) | 18 | 34 | |
| Female | 22 (29.7) | 8 | 14 | |
| Lauren type | 0.232b | |||
| Intestinal | 32 (43.2) | 9 | 23 | |
| Diffuse | 28 (37.8) | 12 | 16 | |
| Mixed | 10 (13.5) | 3 | 7 | |
| Indeterminatec | 4 (5.4) | 2 | 2 | |
| Tumor stage | 0.046d,e | |||
| Stage I | 7 (9.5) | 0 | 7 | |
| Stage II | 7 (9.5) | 2 | 5 | |
| Stage III | 51 (68.9) | 20 | 31 | |
| Stage IV | 9 (12.1) | 4 | 5 | |
| Differentiation | 0.018 | |||
| Poor | 51 (68.9) | 23 | 28 | |
| Well | 20 (27) | 3 | 17 | |
| Indeterminatec | 3 (4.1) | 0 | 3 | |
aDerived from a χ2 test unless otherwise specified. bIntestinal-subtype versus diffuse-subtype. cIndeterminate samples not include for difference tests dstage II & III versus stage I. eDerived from a Fisher’s exact test.